Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/1995
06/22/1995WO1995016690A1 PYRANO[f]QUINOLINE DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
06/22/1995WO1995016685A1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
06/22/1995WO1995016684A1 3-substituted 1-arylindole compounds
06/22/1995WO1995016672A1 Vitamin d amine and amide derivatives
06/22/1995WO1995016663A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995WO1995016659A1 Novel retinoid conjugate compounds and methods for treating skin aging
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy
06/22/1995WO1995016442A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995WO1995016435A2 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995WO1995016353A1 Systemic gene treatment of connective tissue diseases
06/22/1995WO1995015381A3 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995CA2179203A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents
06/22/1995CA2179179A1 3-substituted 1-arylindole compounds
06/22/1995CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995CA2179147A1 Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent
06/22/1995CA2179068A1 Novel potassium channel agonist produced from trichoderma virens
06/22/1995CA2178964A1 Novel retinoid conjugate compounds and methods for treating skin aging
06/22/1995CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2155929A1 Systemic gene treatment of connective tissue diseases
06/22/1995CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
06/22/1995CA2138513A1 Methods of inhibiting myeloperoxidase activity
06/22/1995CA2138508A1 Methods for inhibiting ldl oxidation and atherosclerosis
06/22/1995CA2138498A1 Methods of inhibiting hirsutism and alopecia in women
06/22/1995CA2138495A1 Methods of inhibiting alzheimer's disease
06/22/1995CA2138493A1 Methods of inhibiting thrombin
06/22/1995CA2138492A1 Methods of increasing macrophage function
06/22/1995CA2138457A1 Non-peptide tachykinin receptor antagonists
06/22/1995CA2138454A1 Methods of inhibiting imperfect tissue repair
06/22/1995CA2138100A1 Methods of treating menstrual symptoms and compositions therefor
06/21/1995EP0658557A1 Eburnane derivatives, processes for their preparation and pharmaceutical compositions containing them
06/21/1995EP0658554A1 N-benzyl dihydroindole LTD4 antagonists
06/21/1995EP0658552A1 Process for the preparation of alpha-tocopherol derivatives
06/21/1995EP0658550A2 Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
06/21/1995EP0658546A1 Novel 3-pyrazolecarboxamide derivatives with cannabinoid receptor affinity
06/21/1995EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins
06/21/1995EP0658343A1 Use of 17-beta-hydroxywortmannin and analogs thereof for phosphatidylinositol-3-kinase
06/21/1995EP0658209A1 Endothelial lineage specific transcriptional regulatory element from tek
06/21/1995EP0658199A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells
06/21/1995EP0658198A1 Multicistronic expression units and their use
06/21/1995EP0658169A1 Diamino acid derivatives as antihypertensives
06/21/1995EP0658159A1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
06/21/1995EP0658110A1 Use of norastemizole for the treatment of allergic disorders
06/21/1995EP0658106A1 Thiol derivates for maintaining and/or increasing muscle strength and body cell mass
06/21/1995EP0658099A1 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative.
06/21/1995EP0552292B1 Substituted imidazobenzazepines and imidazopyridoazepines
06/21/1995EP0458959B1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof
06/21/1995EP0411105B1 Bone collagen matrix for implants
06/21/1995CN1104018A Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and use anti-eptic, neuroprotective and antidepressant agents
06/21/1995CN1103871A Bile acid sequestrant
06/21/1995CN1103803A Proprietary traditional Chinese medicine for anti-senility and the prepn. method
06/21/1995CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition
06/20/1995US5426226 Intermediates for making ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
06/20/1995US5426197 Antiinflammatory, antiallergy or antitumor agents
06/20/1995US5426119 Thromboxane antagonists
06/20/1995US5426110 Inhibiting dihydrofolate reductase in mammals and treating susceptible reoplasms
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/20/1995US5425950 Antiserotonine agent
06/16/1995CA2137049A1 Amino acid salts of and methods for preparing antihypercholesterolemic tetrazole compounds
06/15/1995WO1995016209A1 Process for the production of combinatorial compound libraries
06/15/1995WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015979A1 Pretargeting methods and compounds
06/15/1995WO1995015963A1 Bicyclene derivatives, their production and use
06/15/1995WO1995015961A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995WO1995015958A1 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
06/15/1995WO1995015950A1 Compounds
06/15/1995WO1995015949A1 Tricyclic derivatives and their use in pharmaceuticals
06/15/1995WO1995015948A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995WO1995015947A1 Anthracene spiro-pyrrolidines as immuno-modulators
06/15/1995WO1995015946A1 Piperazine-substituted pyrroloanthracene as immuno-moderators
06/15/1995WO1995015945A1 Substituted pyrroloanthracenes and pyrroloanthracene diones as immunomodulators
06/15/1995WO1995015939A1 Tricyclic derivatives, pharmaceutical compositions containing them
06/15/1995WO1995015755A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent
06/15/1995WO1995015752A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995WO1995015747A1 Local delivery of fibrinolysis enhancing agents
06/15/1995WO1995012678A3 Improvements relating to cancer therapy
06/15/1995WO1995009619A3 Substituted urea and isothiourea derivatives as no synthase inhibitors
06/15/1995CA2178634A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177739A1 Novel 2-arylalkenyl-azacycloalkane derivatives as sigma receptor ligands, preparation method therefor and therapeutical use thereof
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/15/1995CA2175701A1 Bicyclic heterocycles as neurokinin a antagonists
06/15/1995CA2175078A1 Process for the production of combinatorial compound libraries
06/15/1995CA2137642A1 N-benzyl dihydroindole ltd4 antagonists
06/15/1995CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
06/15/1995CA2137481A1 Process for the preparation of .alpha.-tocopherol derivatives
06/14/1995EP0657536A1 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding
06/14/1995EP0657520A1 Antioxidant
06/14/1995EP0657468A1 Human stromae derived factor
06/14/1995EP0657458A1 Protein kinase C inhibitors
06/14/1995EP0657454A1 Imidazopyridazines being angiotensin II antagonists
06/14/1995EP0657453A1 Angiotensin converting enzyme (ace) inhibitors containing a fused multiple ring lactam
06/14/1995EP0657452A1 Imidazopyridines
06/14/1995EP0657451A2 Pyrrolidine derivatives inhibitors of leukotriene biosynthesis
06/14/1995EP0657435A2 1,2-Dihydro-2-oxo-pyrimidines
1 ... 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 ... 1564